How Imatinib (Gleevec) Transformed Leukemia Treatment and Cancer Research

Gleevec (Imatinib) was developed with primarily with the help of researches conducted by National Cancer Institute (NCI), and Imatinib was one of the discoveries they made. This Drug has drastically improved the outcomes of patients who were suffering from Blood Cancer primarily Chronic Myelogenous Leukaemia. And due to the discoveries made by NCI that lead to Imatinib, they helped to establish a Targeted Therapy which had revolutionised the field of Cancer Research.

See full Article: https://shorturl.at/tyIL7

#Imatinib #Gleevec #LeukemiaTreatment #cancerresearch #MedicalBreakthrough
#TargetedTherapy #fightagainstcancer #InnovationInMedicine #HopeForPatients #TransformativeTreatment #ResearchAdvancements
#LifeSavingMedication #HealthCareHeroes #ScienceProgress #CancerAwareness #MedicalInnovation